Furosemide Tablet
Product Images NDC 64980-563

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 64980-563). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (76e87a12 C2c0 46dc 93e9 0c4d18373a79 01)

FDA Label Image

Image (76e87a12 C2c0 46dc 93e9 0c4d18373a79 02)

Image (76e87a12 C2c0 46dc 93e9 0c4d18373a79 02)
This is a description of Furosemide Tablets, USP with NDC code 64980-562-01. There are 100 tablets per bottle, each containing 20 mg furosemide. The dosage and administration information can be found in the package insert. There is a warning to keep the medication out of reach of children and not to use if the seal is broken. The pharmacist should dispense it in a well-closed, light-resistant container with a child-resistant closure. Store it at 68°-77°F (20°-25°C), with excursions allowed to 59°-86°F (15°-30°C). It's manufactured by Graviti Pharmaceuticals Pvt. Ltd. in India and licensed under 12/SRD/TS/2017/F/G. The label was issued in 08/2022, and the text "NVZ 45X 15" is unclear and may be a code for internal use.*
FDA Label Image

Image (76e87a12 C2c0 46dc 93e9 0c4d18373a79 03)

Image (76e87a12 C2c0 46dc 93e9 0c4d18373a79 03)
Each tablet of PURising Furosemide contains 40mg of furosemide. The medication is manufactured by Rising Pharmaceuticals, Inc. and the dosage and administration information can be found in the package insert. The product is manufactured by Graviti Pharmaceuticals Pvt. Ltd. in India and caution should be taken to keep it out of reach of children. The medication should not be used if the bottle closure seal is broken. The medication should be dispensed in a well-closed, light-resistant container with a child-resistant closure and stored between 68-77 °F (20-25°C) with controlled excursions between 59-86°F (15-30°C). Issuance of product recommended in August 2022.*
FDA Label Image

Image (76e87a12 C2c0 46dc 93e9 0c4d18373a79 04)

Image (76e87a12 C2c0 46dc 93e9 0c4d18373a79 04)
This is a medication description for Furosemide tablets containing 80 mg of furosemide manufactured by Rising Pharmaceuticals, Inc. The dosage and administration instructions are provided in the packaging insert, and caution is advised for children. The tablets are manufactured by Graviti Pharmaceuticals Pvt. Ltd., based in India. The medication pack should not be used if the closure seal is broken. The pharmacist should dispense the medication in a well-closed, light-resistant container with a child-resistant closure. The medication should be stored at room temperature between 68° to 77°F (20° to 25°C) with excursions permitted to 59° to 86°F (15° to 30°C).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.